CIRIONI, Oscar
 Distribuzione geografica
Continente #
NA - Nord America 14.091
EU - Europa 7.027
AS - Asia 6.808
SA - Sud America 1.476
AF - Africa 392
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 29.823
Nazione #
US - Stati Uniti d'America 13.838
SG - Singapore 2.292
VN - Vietnam 1.379
RU - Federazione Russa 1.257
UA - Ucraina 1.211
BR - Brasile 1.124
CN - Cina 1.060
IT - Italia 741
DE - Germania 685
IE - Irlanda 680
SE - Svezia 663
TR - Turchia 586
HK - Hong Kong 559
FR - Francia 471
DK - Danimarca 433
FI - Finlandia 353
GB - Regno Unito 253
KR - Corea 244
CI - Costa d'Avorio 195
IN - India 150
AR - Argentina 124
CA - Canada 104
MX - Messico 102
BD - Bangladesh 93
EC - Ecuador 62
JP - Giappone 61
NL - Olanda 58
ZA - Sudafrica 58
IQ - Iraq 54
ID - Indonesia 50
CO - Colombia 48
PL - Polonia 44
MA - Marocco 42
PK - Pakistan 41
UZ - Uzbekistan 35
VE - Venezuela 35
AT - Austria 33
PH - Filippine 29
PY - Paraguay 28
BE - Belgio 27
ES - Italia 27
IR - Iran 27
PE - Perù 20
CL - Cile 18
EG - Egitto 18
TN - Tunisia 18
MY - Malesia 16
LT - Lituania 14
RO - Romania 14
KE - Kenya 13
KZ - Kazakistan 13
NP - Nepal 13
SA - Arabia Saudita 13
JO - Giordania 12
AE - Emirati Arabi Uniti 11
AU - Australia 10
OM - Oman 10
UY - Uruguay 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
ET - Etiopia 9
PS - Palestinian Territory 9
TH - Thailandia 9
EU - Europa 8
IL - Israele 8
AZ - Azerbaigian 7
HR - Croazia 7
PA - Panama 7
CH - Svizzera 6
RS - Serbia 6
BO - Bolivia 5
CR - Costa Rica 5
CY - Cipro 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AL - Albania 4
CG - Congo 4
JM - Giamaica 4
LY - Libia 4
PT - Portogallo 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
KW - Kuwait 3
LB - Libano 3
MD - Moldavia 3
MT - Malta 3
NG - Nigeria 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
A1 - Anonimo 2
BB - Barbados 2
Totale 29.782
Città #
Ashburn 2.167
Singapore 1.400
Jacksonville 1.207
Chandler 1.054
Dallas 880
Fairfield 832
Dublin 671
San Jose 647
Boardman 616
Hong Kong 536
Wilmington 490
Ho Chi Minh City 448
Woodbridge 401
New York 375
Hanoi 352
Seattle 322
Houston 316
Ann Arbor 279
Beijing 276
Des Moines 264
Moscow 262
Lawrence 254
Princeton 254
Cambridge 250
San Mateo 247
Lauterbourg 221
The Dalles 217
Los Angeles 212
Abidjan 195
Hefei 168
Munich 125
San Diego 119
Turin 113
São Paulo 98
Buffalo 91
Centro 91
Da Nang 75
Council Bluffs 74
Orem 66
Helsinki 64
Turku 64
Redmond 58
London 56
Santa Clara 51
Tokyo 46
Chicago 45
Haiphong 43
Guangzhou 42
Montreal 40
Chennai 38
Shanghai 38
Warsaw 37
Ancona 35
Tashkent 34
Rio de Janeiro 33
Washington 32
Columbus 31
Mexico City 31
Nuremberg 31
Denver 29
Izmir 29
Johannesburg 29
Norwalk 28
Rome 27
Brussels 26
Manchester 25
Brasília 24
Brooklyn 24
Milan 24
Mumbai 23
Wuhan 23
Falls Church 22
Hải Dương 22
Marche 22
Amsterdam 21
Atlanta 21
Belo Horizonte 20
Poplar 20
Porto 20
Biên Hòa 19
Guayaquil 19
Phoenix 19
San Francisco 18
Dhaka 17
Ottawa 17
Stockholm 17
Vienna 17
Baghdad 16
Boston 16
Bắc Ninh 16
Can Tho 16
Curitiba 16
Frankfurt am Main 16
Salt Lake City 16
Buenos Aires 15
Caracas 15
Kilburn 15
New Delhi 15
Pune 15
Campinas 14
Totale 18.337
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 330
Antimicrobial Resistance: A Challenge for the Future 301
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 263
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 229
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 207
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 205
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 200
Anticryptosporidial activity of paromomycin. 196
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 186
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 184
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 181
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 181
Antimicrobial activity of polycationic peptides 180
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 179
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 179
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 178
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 174
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 169
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 166
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 163
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 162
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 162
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 158
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT 155
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 154
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 152
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 152
Epidemiology and microbiology of surgical wound infections. 150
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 148
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 148
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 148
Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against mbl and esbl co-producing gram-negative clinical isolates: Possible options for the treatment of complicated infections 148
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 146
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 146
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 146
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 145
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 145
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 144
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 144
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 144
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 143
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 142
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 142
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 140
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 139
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 139
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 137
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 136
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 136
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 136
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 136
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 135
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 135
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 135
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 135
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 132
Animal models commonly used to study quorum-sensing inhibitors. 131
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 131
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 131
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 130
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 130
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 130
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 130
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 130
Review: A safety profile of dalbavancin for onand off-label utilization 130
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 129
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 129
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 129
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 129
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 128
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 127
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 125
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 124
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 124
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 123
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 123
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 122
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 121
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 120
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 119
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 119
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 119
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 119
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 118
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 118
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 118
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 118
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 118
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 118
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 117
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 117
Urinary catheters and biofilm formation 117
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 116
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 116
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 116
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 115
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 115
Totale 14.657
Categoria #
all - tutte 132.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021545 0 0 0 0 0 0 0 0 0 0 376 169
2021/20222.026 132 443 13 105 33 147 91 117 142 265 131 407
2022/20233.451 341 334 254 246 267 516 7 182 884 18 273 129
2023/20241.976 363 46 133 319 347 415 34 55 22 23 26 193
2024/20254.249 544 333 248 131 156 213 419 169 892 227 417 500
2025/202611.118 676 930 963 1.299 1.091 751 2.100 1.151 1.069 912 176 0
Totale 30.168